Literature DB >> 36171409

Molecular imaging of fibroblast activity in pressure overload heart failure using [68 Ga]Ga-FAPI-04 PET/CT.

Guokun Wang1, Qinqin Yang2, Chao Cheng3, Suxuan Liu4, Shengyong Wu5, Xudong Xu6, Xiao Li2, Siyu Liang2, Guixia Pan2, Changjing Zuo2, Xianxian Zhao6.   

Abstract

PURPOSE: We aimed to evaluate whether [68 Ga]Ga-FAPI-04 PET/CT could characterize the early stages of cardiac fibrosis in pressure overload heart failure.
METHODS: Sprague-Dawley rats underwent abdominal aortic constriction (AAC) (n = 12) and sham surgery (n = 10). All rats were scanned with [68 Ga]Ga-FAPI-04 PET/CT at 2, 4, and 8 weeks after surgery. The expression of fibroblast activation protein (FAP) in the myocardium was detected by immunohistochemistry. [68 Ga]Ga-FAPI-04 PET signal and FAP expression were compared between two groups.
RESULTS: Compared with the sham group, the AAC group presented with decreased ejection fraction (EF) and fractional shortening (FS) and increased left ventricular internal dimensions in diastole (LVIDd) and systole (LVIDs) at 4 and 8 weeks (all p < 0.01). The AAC group showed higher [68 Ga]Ga-FAPI-04 accumulation in the heart than the sham group at 2, 4, and 8 weeks, and FAPI increased significantly from 2 to 8 weeks (all p < 0.001). Immunohistochemistry confirmed the higher density of the FAP+ area in the AAC group. The intensity of the [68 Ga]Ga-FAPI-04 correlated with the density of the FAP+ area (p < 0.001). The expression of the [68 Ga]Ga-FAPI-04 at 4 weeks correlated with the deterioration of cardiac function at 8 weeks (EF: R =  - 0.87; FS: R =  - 0.72; LVIDd: R = 0.77; LVIDs: R = 0.79; all p < 0.001). The AAC group also showed an increased [68 Ga]Ga-FAPI-04 signal in the liver, peaking at 4 weeks and then declining. Cardiac and liver PET signals correlated at 4 weeks in the AAC group (R = 0.69, p = 0.0010), suggesting an early fibrotic link between organs. A combination of the [68 Ga]Ga-FAPI-04 intensity in the heart and liver at 4 weeks better predicted the deterioration of cardiac function at 8 weeks.
CONCLUSIONS: The activated fibroblasts in the heart and liver after pressure overload can be monitored by [68 Ga]Ga-FAPI-04 PET/CT, which reveals an early fibrotic link in cardio-liver interactions and could better predict nonischemic heart failure prognosis.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  FAPI-PET; Fibroblast activation protein; Heart failure; Molecular imaging; Pressure overload

Year:  2022        PMID: 36171409     DOI: 10.1007/s00259-022-05984-6

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   10.057


  24 in total

Review 1.  Cardiac fibroblasts: at the heart of myocardial remodeling.

Authors:  Karen E Porter; Neil A Turner
Journal:  Pharmacol Ther       Date:  2009-05-19       Impact factor: 12.310

Review 2.  Defining the Cardiac Fibroblast.

Authors:  Malina J Ivey; Michelle D Tallquist
Journal:  Circ J       Date:  2016-10-14       Impact factor: 2.993

3.  Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a 68Ga-Labeled Fibroblast Activation Protein Inhibitor, FAPI-04.

Authors:  Zohreh Varasteh; Sarajo Mohanta; Stephanie Robu; Miriam Braeuer; Yuanfang Li; Negar Omidvari; Geoffrey Topping; Ting Sun; Stephan G Nekolla; Antonia Richter; Christian Weber; Andreas Habenicht; Uwe A Haberkorn; Wolfgang A Weber
Journal:  J Nucl Med       Date:  2019-08-12       Impact factor: 10.057

Review 4.  Relevance of mouse models of cardiac fibrosis and hypertrophy in cardiac research.

Authors:  Vikrant Rai; Poonam Sharma; Swati Agrawal; Devendra K Agrawal
Journal:  Mol Cell Biochem       Date:  2016-10-20       Impact factor: 3.396

5.  68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer.

Authors:  Clemens Kratochwil; Paul Flechsig; Thomas Lindner; Labidi Abderrahim; Annette Altmann; Walter Mier; Sebastian Adeberg; Hendrik Rathke; Manuel Röhrich; Hauke Winter; Peter K Plinkert; Frederik Marme; Matthias Lang; Hans-Ulrich Kauczor; Dirk Jäger; Jürgen Debus; Uwe Haberkorn; Frederik L Giesel
Journal:  J Nucl Med       Date:  2019-04-06       Impact factor: 10.057

6.  What is this image? 2021 image 3 result : Multimodality imaging in primary cardiac myxofibrosarcoma.

Authors:  Yuhua Yang; Yiling Wang; Juyi Lin; Lisha Liu; Shengcai Huang
Journal:  J Nucl Cardiol       Date:  2021-12       Impact factor: 5.952

7.  A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts.

Authors:  Anastasia Loktev; Thomas Lindner; Walter Mier; Jürgen Debus; Annette Altmann; Dirk Jäger; Frederik Giesel; Clemens Kratochwil; Philippe Barthe; Christian Roumestand; Uwe Haberkorn
Journal:  J Nucl Med       Date:  2018-04-06       Impact factor: 10.057

8.  Targeting cardiac fibrosis with engineered T cells.

Authors:  Haig Aghajanian; Toru Kimura; Joel G Rurik; Aidan S Hancock; Michael S Leibowitz; Li Li; John Scholler; James Monslow; Albert Lo; Wei Han; Tao Wang; Kenneth Bedi; Michael P Morley; Ricardo A Linares Saldana; Nikhita A Bolar; Kendra McDaid; Charles-Antoine Assenmacher; Cheryl L Smith; Dagmar Wirth; Carl H June; Kenneth B Margulies; Rajan Jain; Ellen Puré; Steven M Albelda; Jonathan A Epstein
Journal:  Nature       Date:  2019-09-11       Impact factor: 49.962

9.  Early Detection of Checkpoint Inhibitor-Associated Myocarditis Using 68Ga-FAPI PET/CT.

Authors:  Daniel Finke; Markus B Heckmann; Esther Herpel; Hugo A Katus; Uwe Haberkorn; Florian Leuschner; Lorenz H Lehmann
Journal:  Front Cardiovasc Med       Date:  2021-02-25

10.  Imaging of cardiac fibroblast activation in a patient after acute myocardial infarction using 68Ga-FAPI-04.

Authors:  Susan Notohamiprodjo; Stephan G Nekolla; Stephanie Robu; Alberto Villagran Asiares; Christian Kupatt; Tareq Ibrahim; Karl-Ludwig Laugwitz; Marcus R Makowski; Markus Schwaiger; Wolfgang A Weber; Zohreh Varasteh
Journal:  J Nucl Cardiol       Date:  2021-04-15       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.